Cite
HARVARD Citation
Jiang, Y. et al. (2014). Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK. Expert review of pharmacoeconomics & outcomes research. pp. 913-927. [Online].